Aktienkurse | Aktien | Börsenkurse | finanzen.ch

Unternehmen	Datum
Gerresheimer AG	13.07.2017
Südzucker AG (Suedzucker AG)	13.07.2017

Mo	Di	Mi	Do	Fr	Sa	So	KW
					1	2	26
3	4	5	6	7	8	9	27
10	11	12	13	14	15	16	28
17	18	19	20	21	22	23	29
24	25	26	27	28	29	30	30
31							31

06.03.25		Options Corner: Trump Blinking First On Tariffs Presents An Opportunity For Best Buy
06.03.25		How Is The Market Feeling About Bristol-Myers Squibb?
06.03.25		Is CVS Health Gaining or Losing Market Support?
06.03.25		$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
06.03.25		Bitcoin, Ethereum, Dogecoin Trend Lower, XRP Holds Steady As Texas Eyes Strategic BTC Reserve
06.03.25		Assessing LendingTree: Insights From 5 Financial Analysts
06.03.25		A Look Into Enphase Energy Inc's Price Over Earnings
06.03.25		Where Burlington Stores Stands With Analysts
06.03.25		$1000 Invested In Williams-Sonoma 10 Years Ago Would Be Worth This Much Today
06.03.25		Peruvian farmer heads to Germany for legal battle with RWE
06.03.25		Apple AirPods Pro 3 Rumored Release Date: These Are the Improvements I Want to See
06.03.25		Trump Vs. Musk: Tesla To Be Hurt By Tariffs On Mexico Despite Friendship
06.03.25		Simon Property Group Unusual Options Activity
06.03.25		Spotlight on Coca-Cola: Analyzing the Surge in Options Activity
06.03.25		Hundreds of Santander customers in UK hit by banking problems
06.03.25		Total crypto market cap could top $4 trillion in Q2 — Analyst
06.03.25		Intuitive Machines Stock Falls After Uncertain Athena Moon Landing
06.03.25		Ministers plan to shelve VAT tax hit on UK investment funds
06.03.25		Ministers plan to shelve VAT tax hit on UK investment funds
06.03.25		Alzheimer's Drugs From Eli Lilly And Biogen Still Deemed Too Costly For NHS Funding
06.03.25		What’s going into your stocks-and-shares Isa this year?
06.03.25		What’s going into your stocks-and-shares Isa this year?
06.03.25		Nasdaq falls into correction as S&P 500 tests ‘line in the sand.’ Watch these levels.
06.03.25		10 Analysts Assess Northern Trust: What You Need To Know
06.03.25		10 Analysts Have This To Say About Health Catalyst
06.03.25		10 Analysts Assess Plug Power: What You Need To Know
06.03.25		VYNE Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
06.03.25		Breaking Down Kroger: 17 Analysts Share Their Views
06.03.25		EQT Unusual Options Activity For March 06
06.03.25		Intuitive Machines’ second moon lander has run into problems. The stock is sliding.
06.03.25		Starlink Is Rolling Out Its Residential Lite Plan to 15 States, With More Coming
06.03.25		CompoSecure Beats EBITDA Estimates But Analyst Cuts Price Forecast Amid Resolute Spin-Off And Growth Outlook
06.03.25		PDAC: Foreign seizures spotlight legal vigilance
06.03.25		How Is The Market Feeling About Pinnacle West Capital?
06.03.25		How Is The Market Feeling About Richtech Robotics?
06.03.25		What's Going On With IonQ Stock Today?
06.03.25		Hewlett Packard Enterprise Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
06.03.25		What Does the Market Think About AT&T?
06.03.25		AI Chip Leaders Nvidia, AMD, Broadcom Slide Amid Marvell Earnings and US Policy Concerns
06.03.25		JPMorgan Questions Viability of US Crypto Reserve, Cites Issues With Smaller Tokens
06.03.25		Analyst Takes Down Abercrombie & Fitch Price Forecast By 34% Despite Being Bullish - Here's Why
06.03.25		Kiniksa Pharmaceuticals Stock Is Attractive From Valuation Perspective-JP Morgan Analyst
06.03.25		Top Wall Street Forecasters Revamp Gap Price Expectations Ahead Of Q4 Earnings
06.03.25		Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize Resources To Focus On ZW251
06.03.25		Why Zscaler Stock Is Surging Today
06.03.25		Is the Market Bullish or Bearish on Ciena?
06.03.25		Is the Market Bullish or Bearish on Oscar Health?
06.03.25		Short Seller Targets Gorilla Technology Group Stock, Investors Take Profits (UPDATED)
06.03.25		Broadcom Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
06.03.25		ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug